Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients

SOS Oxygene Mediterranee1 site in 1 country120 target enrollmentJanuary 2017

ConditionsChronic Respiratory Disease Hypoxemia

Overview

Phase: N/A
Intervention: Not specified
Conditions: Chronic Respiratory Disease
Sponsor: SOS Oxygene Mediterranee
Enrollment: 120
Locations: 1
Primary Endpoint: oxygen use
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Long-term oxygen therapy (LTOT) is the reference treatment for chronic respiratory failure. This treatment is based on the principle of oxygen supplementation via a source to correct hypoxemia in patients. At present, adherence to this treatment is difficult to evaluate (reporting by patients), but the results of the literature show poor LTOT compliance. It is therefore important to accurately measure the oxygen consumption by patients and to understand the factors explaining LTOT compliance. The ultimate aim is to improve our patient management to make them more observant in order to improve the therapeutic efficacy of the treatment.

Registry

clinicaltrials.gov

Start Date

January 2017

End Date

January 1, 2020

Last Updated

5 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

SOS Oxygene Mediterranee

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•chronic respiratory disease patients with chronic hypoxemia
•First prescribed long term oxygenotherapy

Exclusion Criteria

•patients with NIV and CPAP
•vital pronostic \< 3 months

Outcomes

Primary Outcomes

oxygen use

Time Frame: 6 month

time of oxygen use

Secondary Outcomes

precarity score assessed by a questionnaire (EPICE)(baseline)
quality of life assessed by a questionnaire (VQ-11)(baseline, 3 month and 6 month)
respiratory disease severity based on GOLD standards(baseline)